Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer Ruchika Sharma19 Aug 2025 2:15 PM ISTPrinceton: SystImmune Inc., a clinical-stage biotechnology company, and Bristol Myers Squibb have announced that the U.S. Food and Drug...
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer Ruchika Sharma19 Aug 2025 12:30 PM ISTRahway: Merck and Daiichi Sankyo have announced that Ifinatamab deruxtecan (I-DXd) has been granted Breakthrough Therapy Designation (BTD) by the...
Alcohol Use Disorder and High-Risk Drinking Linked to Worse COVID-19 Outcomes Dr Riya Dave18 Aug 2025 8:45 PM ISTResearchers have determined that patients with alcohol use disorder (AUD) and excessive alcohol use are greatly at risk of severe COVID-19 outcomes,...
Precigen secures full USFDA nod for Papzimeos for adults with Recurrent Respiratory Papillomatosis Ruchika Sharma18 Aug 2025 12:30 PM ISTGermantown: Precigen, Inc., a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve...
Hospitalisation in COPD Patients Linked to Sharp Rise in Cardiovascular Events and Mortality: Study Medha Baranwal17 Aug 2025 8:45 PM ISTUK: A recent study published in the International Journal of Chronic Obstructive Pulmonary Disease highlights a concerning link between...
FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis Dr. Kamal Kant Kohli15 Aug 2025 8:30 PM ISTThe FDA has approved oral brensocatib (Brinsupri) for adults and children 12+ with non-cystic fibrosis bronchiectasis. As a first-in-class reversible...
PCV20 Launch in India: A Single Dose, Science-Driven Approach for Pneumococcal Disease Control Deeksha Bhandari14 Aug 2025 12:12 PM ISTA next-generation pneumococcal conjugate vaccine, PCV20, a single-dose protection is now available in India marking a new milestone in adult ...
FDA Approves Genio System for Moderate to Severe OSA Dr. Kamal Kant Kohli13 Aug 2025 8:45 PM ISTThe FDA has approved the Genio system for treating patients with moderate to severe obstructive sleep apnea (OSA) with an apnea-hypopnea index (AHI)...
Tetracyclines Reduce Fever and Hospital Stay in Mycoplasma pneumoniae Patients: Study Jacinthlyn Sylvia12 Aug 2025 9:00 PM ISTA new study published in the journal of Open Forum Infectious Diseases showed that tetracyclines are associated with shorter hospital stays and fever...
Ancient practice of blowing through conch shell could help to treat dangerous snoring condition: Study Dr. Kamal Kant Kohli11 Aug 2025 9:15 PM ISTPeople who practised blowing through a conch shell regularly for six months experienced a reduction in their symptoms of obstructive sleep apnoea...
FDA Grants Accelerated Approval to Zongertinib for HER2-Mutated NSCLC Dr. Kamal Kant Kohli11 Aug 2025 8:15 PM ISTThe FDA has granted accelerated approval to zongertinib (Hernexeos) for treating non-squamous non-small cell lung cancer patients with HER2 tyrosine...
Long-Term Passive Smoking Doubles COPD Risk in Women, Study Finds Medha Baranwal10 Aug 2025 8:45 PM ISTChina: A new community-based study from Jinan, China, has revealed that women with long-term exposure to secondhand smoke face a significantly higher...
